Connect with us

Health

IBD drug may dampen response to COVID-19 vaccine – Medical News Today

People using Remicade, which is a drug that treats inflammatory bowel disease, have a lower antibody response after one dose of a COVID-19 vaccine.

Published

on

Article feature image

  • A large-scale study has found that people using Remicade, which is a drug that treats a number of autoimmune conditions, have a lower antibody response after one dose of a COVID-19 vaccine.
  • Antibody levels were even lower after one vaccine dose in people using Remicade in combination with immunomodulatory drugs.
  • However, having had a previous SARS-CoV-2 infection or a second vaccine dose resulted in an improved antibody response.
  • The researchers recommend that healthcare professionals prioritize people…

Click here to view the original article.